Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Bupivacaine
Homo sapiens
Drug Action Pathway
Bupivacaine is a local anesthetic for surgery, most commonly for oral or obstetrical procedures. It is adminstered via intrathecal injection or directly to the wound site. Bupivacaine does this through blocking the generation of action potential through increasing the threshold for activation. This in turn slows the propagation of the nerve impulse prevents the depolarization by binding to the intracellular portion of the sodium channels and blocking the ions influx into the neurons. Bupivacaine can also potentially bind to prostaglandin E2 receptors, subtype EP1 that stops the production of prostaglandins, reduce fever, inflammation and hyperalgesia. It is metabolized by the liver via glucuronic acid into the metabolite of 2,6-pipecoloxylidine by cytochrome P450 3A4. It is excreted via urine mainly unchanged.
References
Bupivacaine References
Shafiei FT, McAllister RK, Lopez J: Bupivacaine
Pubmed: 30422478
Shafiei FT, McAllister RK, Lopez J: Bupivacaine
Pubmed: 30422478
Babst CR, Gilling BN: Bupivacaine: a review. Anesth Prog. 1978 May-Jun;25(3):87-91.
Pubmed: 373511
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Settings